Skip to main content
Equibles

EPRX · Eupraxia Pharmaceuticals Inc. · Documents

Use EPRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EPRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
9.2300 CAD -0.2500 (-2.64%) At close · Nov 5 Intraday price with Plus
Rebalance outlook locked

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

2026
Mar 13
Annual report 40-F FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $0 Net loss $38.58M Diluted EPS -$1.03
Mar 12
Report SEDAR+
MD&A
Feb 19 to Feb 18
Offering documents SEDAR+
5 offering documents
  • Underwriting or agency agreements (or amendment thereto) 1
  • Draft shelf prospectus supplement 1
  • Shelf prospectus (NI 44-102) 1
  • Consent letter of issuer's legal counsel 1
  • Other offering documents 1
2025
Nov 4
Report SEDAR+
MD&A
Showing 51–100 of 414 documents